These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 8098029)

  • 1. Erratic zidovudine bioavailability in HIV seropositive patients.
    Macnab KA; Gill MJ; Sutherland LR; De Boer Visser N; Church D
    J Antimicrob Chemother; 1993 Mar; 31(3):421-8. PubMed ID: 8098029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zidovudine absorption and small intestinal function in HIV seropositive patients.
    Macnab KA; Gill MJ; Sutherland LR; Murphy A; Brant R
    J Antimicrob Chemother; 1996 Apr; 37(4):825-9. PubMed ID: 8722550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic evaluations of low- and high-dose zidovudine plus high-dose acyclovir in patients with symptomatic human immunodeficiency virus infection.
    Tartaglione TA; Collier AC; Opheim K; Gianola FG; Benedetti J; Corey L
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2225-31. PubMed ID: 1803995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of zidovudine in HIV-positive patients with liver disease.
    Bareggi SR; Cinque P; Mazzei M; D'Arminio A; Ruggieri A; Pirola R; Nicolin A; Lazzarin A
    J Clin Pharmacol; 1994 Jul; 34(7):782-6. PubMed ID: 7929874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zidovudine bioavailability and linear pharmacokinetics in female B6C3F1 mice.
    Trang JM; Prejean JD; James RH; Irwin RD; Goehl TJ; Page JG
    Drug Metab Dispos; 1993; 21(1):189-93. PubMed ID: 8095218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy with recombinant human soluble CD4-immunoglobulin G and zidovudine in patients with HIV infection: a phase I study.
    Meng TC; Fischl MA; Cheeseman SH; Spector SA; Resnick L; Boota A; Petrakis T; Wright B; Richman DD
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Feb; 8(2):152-60. PubMed ID: 7834398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absorption of zidovudine in patients with diarrhoea.
    Zorza G; Beaugerie L; Taburet AM; Le Quintrec Y; Singlas E
    Eur J Clin Pharmacol; 1993; 44(5):501-3. PubMed ID: 8359192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between body weight, body surface area and serum zidovudine pharmacokinetic parameters in adult, male HIV-infected patients.
    Sahai J; Gallicano K; Ormsby E; Garber G; Cameron DW
    AIDS; 1994 Jun; 8(6):793-6. PubMed ID: 8086138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urine levels of rifampicin & isoniazid in asymptomatic HIV-positive individuals.
    Ramachandran G; Hemanth Kumar AK; Sarala K; Padmapriyadarsini C; Anitha S; Tharani CB; Kumaraswami V; Swaminathan S
    Indian J Med Res; 2007 Jun; 125(6):763-6. PubMed ID: 17704553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic disposition of zidovudine during pregnancy.
    Watts DH; Brown ZA; Tartaglione T; Burchett SK; Opheim K; Coombs R; Corey L
    J Infect Dis; 1991 Feb; 163(2):226-32. PubMed ID: 1988507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of disease stage and zidovudine therapy on the detection of human immunodeficiency virus type 1 in semen.
    Anderson DJ; O'Brien TR; Politch JA; Martinez A; Seage GR; Padian N; Horsburgh CR; Mayer KH
    JAMA; 1992 May; 267(20):2769-74. PubMed ID: 1349654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of the pharmacokinetics of zidovudine in man.
    Cload PA
    J Infect; 1989 Jan; 18 Suppl 1():15-21. PubMed ID: 2915139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative pharmacokinetics of zidovudine (AZT) and its metabolite (G.AZT) in healthy subjects and HIV seropositive patients.
    Singlas E; Pioger JC; Taburet AM; Colaneri S; Fillastre JP
    Eur J Clin Pharmacol; 1989; 36(6):639-40. PubMed ID: 2776824
    [No Abstract]   [Full Text] [Related]  

  • 14. Zidovudine in persons with asymptomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimeter. The European-Australian Collaborative Group.
    Cooper DA; Gatell JM; Kroon S; Clumeck N; Millard J; Goebel FD; Bruun JN; Stingl G; Melville RL; González-Lahoz J
    N Engl J Med; 1993 Jul; 329(5):297-303. PubMed ID: 8100611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of a protein meal on zidovudine pharmacokinetics in HIV-infected patients.
    Sahai J; Gallicano K; Garber G; McGilveray I; Hawley-Foss N; Turgeon N; Cameron DW
    Br J Clin Pharmacol; 1992 Jun; 33(6):657-60. PubMed ID: 1389940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors predictive of maternal-fetal transmission of HIV-1. Preliminary analysis of zidovudine given during pregnancy and/or delivery.
    Boyer PJ; Dillon M; Navaie M; Deveikis A; Keller M; O'Rourke S; Bryson YJ
    JAMA; 1994 Jun 22-29; 271(24):1925-30. PubMed ID: 7911164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized controlled trial of a protease inhibitor (saquinavir) in combination with zidovudine in previously untreated patients with advanced HIV infection.
    Vella S; Lazzarin A; Carosi G; Sinicco A; Armignacco O; Angarano G; Andreoni M; Tambussi G; Chiodera A; Floridia M; Scaccabarozzi S; Facey K; Duncan I; Boudes P; Bragman K
    Antivir Ther; 1996 Aug; 1(3):129-40. PubMed ID: 11322246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-seropositive thrombocytopenia: the action of zidovudine.
    Boyar A; Beall G
    AIDS; 1991 Nov; 5(11):1351-6. PubMed ID: 1768384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of oral zidovudine (azidothymidine) in patients with AIDS when administered with and without a high-fat meal.
    Unadkat JD; Collier AC; Crosby SS; Cummings D; Opheim KE; Corey L
    AIDS; 1990 Mar; 4(3):229-32. PubMed ID: 2350441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic interaction between zidovudine and valproic acid in patients infected with human immunodeficiency virus.
    Lertora JJ; Rege AB; Greenspan DL; Akula S; George WJ; Hyslop NE; Agrawal KC
    Clin Pharmacol Ther; 1994 Sep; 56(3):272-8. PubMed ID: 7924122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.